| Active ingredients |
| Date of last message | Type of reason | AM designation | |
| Atomoxetine hydrochloride | Change notification | 30.01.2026 | Other | Atomoxe – 1 A Pharma 10 mg hard capsules | |
| Valaciclovir hydrochloride | Change notification | 30.01.2026 | Other | Valaciclovir – 1A Pharma 500 mg film-coated tablets | |
| Salbutamol sulfate | Change notification | 30.01.2026 | Other | SalbuHEXAL N metered-dose inhaler | |
| Salbutamol sulfate | Change notification | 30.01.2026 | Other | Salbutamol – 1 A Pharma 0.1 mg pressurized gas inhalation, suspension | |
| Lorazepam | Change notification | 30.01.2026 | Other | Tavor 2.5 mg Expidet | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 30.01.2026 | Production problem | Quetiapine – 1 A Pharma 600 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 30.01.2026 | Production problem | Quetiapine – 1 A Pharma 50 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 30.01.2026 | Production problem | Quetiapine – 1 A Pharma 300 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 30.01.2026 | Production problem | Quetiapine – 1 A Pharma 200 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 30.01.2026 | Production problem | Quetiapine – 1 A Pharma 150 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 30.01.2026 | Production problem | Quetiapine HEXAL 50 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 30.01.2026 | Production problem | Quetiapine HEXAL 400 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 30.01.2026 | Production problem | Quetiapine HEXAL 200 mg prolonged-release tablets | |
| Methylphenidate hydrochloride | Change notification | 30.01.2026 | Other | Methylphenidate hydrochloride HEXAL 36 mg prolonged-release tablets | |
| Levetiracetam | Change notification | 30.01.2026 | Other | Levetiracetam – 1 A Pharma 1500 mg film-coated tablets | |
| Ciprofloxacin hydrochloride (1:1) 1 H<2>O | Change notification | 30.01.2026 | Other | Ciprohexal 100 mg | |
| Ciprofloxacin hydrochloride (1:1) 1 H<2>O | Change notification | 30.01.2026 | Other | Cipro-1 A Pharma 100 mg | |
| Trimipramine mesylate | Change notification | 30.01.2026 | Other | Trimipramine – 1 A Pharma 40 mg/ml Oral drops, solution | |
| Oxytocin | Change notification | 30.01.2026 | Production problem | Oxytocin 3 I.E. Hexal | |
| Insulin glargine | Change notification | 30.01.2026 | Other | Semglee | |
| Alprazolam | Change notification | 30.01.2026 | Other | Alprazolam – 1 A Pharma 0.5 mg tablets | |
| Chlortalidone | Change notification | 30.01.2026 | Other | Chlortalidone HEXAL 12.5 mg tablets | |
| Dinoprostone | Change notification | 30.01.2026 | Other | Propess 10 mg vaginal delivery system | |
| Rifampicin | Change notification | 30.01.2026 | Production problem | Eremfat syrup | |
| Ezetimibe; simvastatin | Change notification | 30.01.2026 | Production problem | EZETIMIB/SIMVA BASICS 10 mg/80 mg tablets | |
| Ezetimibe; simvastatin | Change notification | 30.01.2026 | Production problem | EZETIMIB/SIMVA BASICS 10 mg/40 mg tablets | |
| Ezetimibe; simvastatin | Change notification | 30.01.2026 | Production problem | EZETIMIB/SIMVA BASICS 10 mg/20 mg tablets | |
| Ezetimibe; simvastatin | Change notification | 30.01.2026 | Production problem | EZETIMIB/SIMVA BASICS 10 mg/10 mg tablets | |
| Ciprofloxacin hydrochloride monohydrate | Change notification | 30.01.2026 | Other | CIPRO BASICS 750 mg film-coated tablets | |
| Ciprofloxacin hydrochloride monohydrate | Change notification | 30.01.2026 | Other | CIPRO BASICS 250 mg film-coated tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 30.01.2026 | Other | ATORVASTATIN BASICS 30 mg film-coated tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 30.01.2026 | Other | ATORVASTATIN BASICS 20 mg film-coated tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 30.01.2026 | Other | ATORVASTATIN BASICS 10 mg film-coated tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 30.01.2026 | Other | ATORVASTATIN BASICS 80 mg film-coated tablets | |
| Candesartan cilexetil | Change notification | 30.01.2026 | Other | CANDESARTAN BASICS 32 mg tablets | |
| Candesartan cilexetil | Change notification | 30.01.2026 | Other | CANDESARTAN BASICS 16 mg tablets | |
| Candesartan cilexetil | Change notification | 30.01.2026 | Other | CANDESARTAN BASICS 8 mg tablets | |
| Candesartan cilexetil | Change notification | 30.01.2026 | Other | CANDESARTAN BASICS 4 mg tablets | |
| Esomeprazole hemimagnesium | Change notification | 30.01.2026 | Production problem | ESOMEPRAZOLE BASICS 40 mg gastro-resistant hard capsules | |
| Esomeprazole hemimagnesium | Change notification | 30.01.2026 | Production problem | ESOMEPRAZOLE BASICS 20 mg gastro-resistant hard capsules | |
| Quetiapine fumarate (Ph.Eur.) | Initial report | 30.01.2026 | Other | Seroquel Prolong 400 mg prolonged-release tablets | |
| Clonidine hydrochloride | Initial report | 29.01.2026 | Other | Catapresan 300 | |
| Pramipexole dihydrochloride monohydrate | Change notification | 29.01.2026 | Other | Pramipexole-ratiopharm 0.52 mg prolonged-release tablets | |
| Folic acid hydrate (with information on water content (1:x)) | Initial report | 29.01.2026 | Production problem | Folsan 0.4 mg | |
| Methyldopa (Ph.Eur.) | Initial report | 29.01.2026 | Production problem | Presinol 500 | |
| Prednicarbat | Initial report | 29.01.2026 | Other | Prednitop Crinale | |
| Mometasone furoate (Ph.Eur.) | Change notification | 29.01.2026 | Production problem | Momecutan solution | |
| Imatinib mesylate | Initial report | 28.01.2026 | Other | Imatinib Denk 100 mg film-coated tablets | |
| Amlodipine besylate; Perindopril tert-butylamine | Change notification | 28.01.2026 | Other | Perindopril/Amlodipine Denk 4 mg/10 mg tablets | |
| Amlodipine besylate; Perindopril tert-butylamine | Change notification | 28.01.2026 | Other | Perindopril/Amlodipine Denk 8 mg/10 mg tablets | |
| Rifampicin sodium | Change notification | 28.01.2026 | Other | Eremfat i.v. 600mg | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 28.01.2026 | Other | Quetiapine AL 50 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 28.01.2026 | Other | Quetiapine AL 150 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 28.01.2026 | Other | Quetiapine AL 300 mg prolonged-release tablets | |
| Aprepitant | Change notification | 28.01.2026 | Other | Aprepitant AL 80 mg hard capsules | |
| Aprepitant | Change notification | 28.01.2026 | Other | Aprepitant AL 125 mg hard capsules | |
| Nitrendipine | Change notification | 28.01.2026 | Other | Nitrendipine AL 20 | |
| Nitrendipine | Change notification | 28.01.2026 | Other | Nitrendipine AL 10 | |
| Methylphenidate hydrochloride | Change notification | 28.01.2026 | Other | METHYLPHENIDATE 20 mg tablets | |
| Thioctic acid trometamol salt (1:1) | Initial report | 28.01.2026 | Other | Thioctacid 600 T | |
| Duloxetine hydrochloride | Initial report | 27.01.2026 | Production problem | Duloxetine Zentiva 30 mg gastro-resistant hard capsules | |
| Duloxetine hydrochloride | Initial report | 27.01.2026 | Production problem | Duloxetine Zentiva 60 mg gastro-resistant hard capsules | |
| Doxepin hydrochloride (Ph.Eur.) | Change notification | 27.01.2026 | Other | Doxepin 50 Holsten | |
| Gabapentin | Change notification | 27.01.2026 | Other | Gabapentin Holsten 100 mg hard capsules | |
| Moxifloxacin hydrochloride (Ph.Eur.) ((with information on water content (1:x))) | Change notification | 27.01.2026 | Other | Moxifloxacin Holsten 400 mg film-coated tablets | |
| Atomoxetine hydrochloride | Change notification | 27.01.2026 | Production problem | Atomoxetine-neuraxpharm 100 mg hard capsules | |
| Atomoxetine hydrochloride | Change notification | 27.01.2026 | Production problem | Atomoxetine-neuraxpharm 80 mg hard capsules | |
| Atomoxetine hydrochloride | Change notification | 27.01.2026 | Production problem | Atomoxetine-neuraxpharm 40 mg hard capsules | |
| Atomoxetine hydrochloride | Change notification | 27.01.2026 | Production problem | Atomoxetine-neuraxpharm 25 mg hard capsules | |
| Atomoxetine hydrochloride | Change notification | 27.01.2026 | Production problem | Atomoxetine-neuraxpharm 18 mg hard capsules | |
| Atomoxetine hydrochloride | Change notification | 27.01.2026 | Production problem | Atomoxetine-neuraxpharm 10 mg hard capsules | |
| Atomoxetine hydrochloride | Change notification | 27.01.2026 | Production problem | Atomoxetine-neuraxpharm 60 mg hard capsules | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 26.01.2026 | Other | Atorvastatin Micro Labs 60 mg film-coated tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 26.01.2026 | Other | Atorvastatin Micro Labs 30 mg film-coated tablets | |
| Fluoxetine hydrochloride | Change notification | 26.01.2026 | Other | Fluoxetine Micro Labs 60 mg hard capsules | |
| Fluoxetine hydrochloride | Change notification | 26.01.2026 | Other | Fluoxetine Micro Labs 30 mg hard capsules | |
| Naloxone hydrochloride dihydrate; oxycodone hydrochloride (Ph.Eur.) | Change notification | 26.01.2026 | Production problem | Targin 40 mg/20 mg prolonged-release tablets | |
| Zonisamide | Change notification | 26.01.2026 | Production problem | Zonisamide Glenmark 100 mg hard capsules | |
| Levofloxacin hemihydrate | Change notification | 26.01.2026 | Production problem | Levofloxacin Kabi 5 mg/ml solution for infusion | |
| Ciprofloxacin sulfate (1:1) | Change notification | 26.01.2026 | Production problem | Ciprofloxacin Kabi 200 mg/100 ml solution for infusion | |
| Rizatriptan benzoate | Change notification | 26.01.2026 | Production problem | Rizatriptan Glenmark 5 mg tablets | |
| Rizatriptan benzoate | Change notification | 26.01.2026 | Production problem | Rizatriptan Glenmark 5 mg orodispersible tablets | |
| Quetiapine fumarate (Ph.Eur.) | Initial report | 26.01.2026 | Production problem | Quetiapine Glenmark 50 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 26.01.2026 | Production problem | Quetiapine Glenmark 150 mg prolonged-release tablets |
| Ingredients | Product Name | Formulation | Report Category | Report Date |
| Polysaccharide Iron Complex | Hemonia Capsule (Polysaccharide Iron Chelate) | Hard Capsule, Powder | Supply Discontinuation | 2026-01-30 |
| Fluvastatin Sodium | Rescol XL Extended-Release Tablets (Fluvastatin Sodium) | Extended-Release Film-Coated Tablets | Supply Discontinuation | 2026-01-29 |
| Talazoparib Tosylate | Talzena Capsule 1 Milligram (Talazoparib Tosylate) | Hard Capsule, Powder | Supply Discontinuation | 2026-01-28 |
| Haloperidol Decanoate | Haloperidol Decanoate Injection (Haloperidol Decanoate) | Solution for Injection | Supply Shortage | 2026-01-28 |
| Bacillus licheniformis, Calcium Pantothenate | Biscanbic Acid | Powder | Supply Discontinuation | 2026-01-28 |
| Human Papillomavirus-16 L1 (Host: Trichoplusia ni Hi-5 Rix4446, Vector: rBaculo4449), Human Papillomavirus-18 L1 (Host: Trichoplusia ni Hi-5 Rix4446, Vector: rBaculo4450) | Suvarix Prefilled Syringe [Human Papillomavirus Vaccine (Recombinant)] | Suspension for Injection | Supply Discontinuation | 2026-01-23 |
| Sodium Bicarbonate | Daewon Sodium Bicarbonate Injection (8.4%) | Solution for Injection | Supply Shortage | 2026-01-22 |
| Ketorolac Tromethamine | Acuveil Eye Drops 0.45% (Ketorolac Tromethamine) (Single-Use) | Eye Drops | Supply Shortage | 2026-01-21 |
| Dilazep Hydrochloride Hydrate | Bukwang Comelian Tablets 50 milligrams (Dilazep Hydrochloride Hydrate) | Film-coated Tablet | Supply Discontinuation | 2026-01-15 |
| Dacarbazine | DTIC Injection 200 Milligrams (Dacarbazine) (Export Name: DTIC-VHB for injection, Duticin for injection) | Freeze-Dried Powder for Solution for Injection | Supply Discontinuation | 2026-01-15 |
| Vinblastine Sulfate | Vinblastine Sulfate Injection | Freeze-Dried Powder for Solution for Injection | Supply Discontinuation | 2026-01-15 |
| Mecuitazine | Primaran Tablets (Mequitazine) | Najeong | Supply Discontinuation | 2026-01-15 |
| Dacarbazine | DTIC Injection (Dacarbazine) (Export Name: DTIC-VHB for injection 100mg) | Freeze-Dried Powder for Solution for Injection | Supply Discontinuation | 2026-01-15 |
| Deferasirox | Exzide Film-Coated Tablets 180 milligrams (Deferasirox) | Film-coated Tablet | Supply Shortage | 2026-01-14 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 40 milligrams (Oxycodone Hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Dexketoprofen Trometamol | Keral (Dexketoprofen Trometamol) | Solution for Injection | Supply Discontinuation | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 10 milligrams (oxycodone hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 20 milligrams (oxycodone hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 80mg (Oxycodone Hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Nalbuphine Hydrochloride | Hanabupine Hydrochloride Injection 10mg | Solution for Injection | Supply Discontinuation | 2026-01-05 |
| Nimodipine | Cerebonal Tablets (Nimodipine) | Film-coated Tablet | Supply Discontinuation | 2026-01-05 |
| Active ingredients | Status | Update | Specialty |
| synthetic vitamin A concentrate, oil form | Marketing discontinuation | 30/01/2026 | Vitamin A Dulcis 25,000 IU per 100 g, ophthalmic ointment – (imported from Vitamin A Blache) |
| 131I CIS Bio International 7.5 to 15 MBq/mL solution for injection | Stock shortage | 29/01/2026 | Iodinated norcholesterol |
| oxybuprocaine hydrochloride | Supply tension | 29/01/2026 | Oxybuprocaine hydrochloride Thea 1.6 mg/0.4 ml, eye drops in single-dose containers Boxes of 20 single doses and boxes of 100 single doses |
| tropicamide | Supply tension | 29/01/2026 | Mydriaticum 2 mg/0.4 ml, eye drops in single-dose container – |
| Paracetamol | Return to availability | 29/01/2026 | Paracetamol, suppository forms 300 mg, 200 mg, 150 mg, 100 mg, and 80 mg |
| ondansetron | Supply tension | 29/01/2026 | Zophren 2 mg/mL, injectable solution in ampoule (IV) |
| fluorouracil | Stock shortage | 29/01/2026 | Fluorouracil Pfizer 50 mg/mL, solution for dilution for infusion – 20 mL and 100 mL vials |
| human plasma albumin (macroaggregates of) | Supply tension | 28/01/2026 | Pulmocis 2 mg, kit for radiopharmaceutical preparation |
| benzathine benzylpenicillin | Supply tension | 28/01/2026 | Extencilline 2.4 MUI, powder and solvent for IM injection suspension |
| benzathine benzylpenicillin | Supply tension | 28/01/2026 | Extencilline 1.2 MUI, powder and solvent for IM injection suspension |
| caffeine, opium (dry extract of), paracetamol | Supply tension | 28/01/2026 | Lamaline, suppository |
| cilastatin sodium, imipenem monohydrate, relebactam monohydrate | Supply tension | 27/01/2026 | Recarbrio 500 mg/500 mg/250 mg, powder for solution for infusion |
| tetracaine hydrochloride | Stock shortage | 26/01/2026 | Tetracaine 1% Théa, eye drops in single-dose container |
| trastuzumab | Stock shortage | 26/01/2026 | Ogivri 150 mg, powder for solution for infusion |
| piperacillin sodium | Supply tension | 26/01/2026 | Piperacillin Panpharma 4 g, powder for solution for injection (I.M., I.V.) |
| cyamemazine | Return to availability | 26/01/2026 | Tercian 50 mg/5 mL, injectable solution in ampoule |
| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| rifabutin | Capsule, hard | 150 mg | Anticipated | Available | Manufacturing | 1/02/2026 |
| zolpidem tartrate | Tablet, film coated | 10 mg | Anticipated | Available | Manufacturing | 30/01/2026 |
| calcitonin salmon | Injection, solution | 100 IU/mL | Anticipated | Available | Unexpected increase in consumer demand | 30/01/2026 |
| topiramate | Tablet, film coated | 25 mg | Anticipated | Available | Manufacturing | 30/01/2026 |
| moclobemide | Tablet, film coated | 300 mg | Anticipated | Available | Manufacturing | 30/01/2026 |
| clevidipine | Injection, emulsion | 25 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 30/01/2026 |
| gabapentin | Capsule, hard | 300 mg | Current | Limited Availability | Manufacturing | 30/01/2026 |
| levetiracetam | Injection, intravenous infusion | 100 mg/mL | Anticipated | Available | Manufacturing | 30/01/2026 |
| pramipexole dihydrochloride monohydrate | Tablet, modified release | .75 mg | Anticipated | Available | Manufacturing | 30/01/2026 |
| avanafil | Tablet, uncoated | 200 mg | Current | Limited Availability | Unexpected increase in consumer demand | 30/01/2026 |
| telmisartan~amlodipine besilate | Tablet, film coated | 40 mg~13.87 mg | Current | Limited Availability | Unexpected increase in consumer demand | 30/01/2026 |
| telmisartan~amlodipine besilate | Tablet, film coated | 40 mg~6.935 mg | Current | Limited Availability | Unexpected increase in consumer demand | 30/01/2026 |
| quetiapine fumarate | Tablet, modified release | 345 mg | Anticipated | Available | Unexpected increase in consumer demand | 30/01/2026 |
| lamotrigine | Tablet, chewable | 50 mg | Anticipated | Available | Manufacturing | 30/01/2026 |
| daunorubicin hydrochloride | Injection, powder for | 20 mg | Anticipated | Available | Manufacturing | 30/01/2026 |
| Interferon gamma1b | Injection, solution | 4 million IU/mL | Discontinued | Unavailable | Commercial Changes / Commercial viability | 30/01/2026 |
| norethisterone~ethinylestradiol | Tablet, uncoated | 500 microgram~36 microgram | Current | Limited Availability | Manufacturing | 30/01/2026 |
| rifampicin | Oral Liquid | 20 mg/mL | Resolved | Available | Unexpected increase in consumer demand | 29/01/2026 |
| atracurium besilate | Injection, intravenous infusion | 10 mg/mL | Resolved | Available | Manufacturing | 29/01/2026 |
| calcium polystyrene sulfonate | Powder | 999.3 mg/g | Resolved | Available | Manufacturing | 29/01/2026 |
| lidocaine | Spray, solution | 100 mg/mL | Current | Unavailable | Manufacturing | 29/01/2026 |
| dantrolene sodium hemiheptahydrate | Injection, powder for | 20 mg | Resolved | Available | Manufacturing | 29/01/2026 |
| benzathine benzylpenicillin tetrahydrate | Injection, suspension | 1200000 USP Unit | Current | Limited Availability | Manufacturing | 29/01/2026 |
| lamotrigine | Tablet, chewable | 200 mg | Current | Limited Availability | Manufacturing | 29/01/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Current | Limited Availability | Manufacturing | 29/01/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Limited Availability | Manufacturing | 29/01/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Resolved | Available | Manufacturing | 29/01/2026 |
| isotretinoin | Capsule, soft | 10 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| isotretinoin | Capsule, soft | 20 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| phenobarbital | Tablet, uncoated | 30 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| temozolomide | Capsule, hard | 20 mg | Current | Limited Availability | Manufacturing | 29/01/2026 |
| ezetimibe~simvastatin | Tablet | 10 mg~40 mg | Current | Limited Availability | Manufacturing | 29/01/2026 |
| midazolam | Injection, solution | 50 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| propofol | Injection, emulsion | 10 mg/mL | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 29/01/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Unavailable | Unexpected increase in consumer demand | 29/01/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| rifampicin | Capsule | 150 mg | Current | Emergency Supply Only | Manufacturing | 29/01/2026 |
| pregabalin | Capsule, hard | 25 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| isotretinoin | Capsule, soft | 10 mg | Current | Limited Availability | Manufacturing | 29/01/2026 |
| isotretinoin | Capsule, soft | 20 mg | Current | Limited Availability | Manufacturing | 29/01/2026 |
| quetiapine fumarate | Tablet, modified release | 57.5 mg | Resolved | Available | Unexpected increase in consumer demand | 29/01/2026 |
| quetiapine fumarate | Tablet, modified release | 172.5 mg | Anticipated | Available | Unexpected increase in consumer demand | 29/01/2026 |
| ezetimibe | Tablet, uncoated | 10 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 29/01/2026 |
| codeine phosphate hemihydrate | Oral Liquid | 5 mg/mL | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 29/01/2026 |
| tranexamic acid | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| cyproterone acetate | Tablet, uncoated | 100 mg | Current | Limited Availability | Manufacturing | 29/01/2026 |
| olmesartan medoxomil~hydrochlorothiazide | Tablet | 40 mg~12.5 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| cinacalcet hydrochloride | Tablet, film coated | 99 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| dabigatran etexilate mesilate | Capsule, hard | 172.95 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| teriflunomide | Tablet, film coated | 14 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| dimethyl fumarate | Capsule, enteric | 240 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| aprepitant | Capsule, hard | 165 mg | Anticipated | Available | Manufacturing | 29/01/2026 |
| tamoxifen citrate | Tablet | 30.34 mg | Anticipated | Available | Manufacturing | 29/01/2026 |
| metformin hydrochloride | Tablet, modified release | 1000 mg | Current | Limited Availability | Manufacturing | 29/01/2026 |
| isotretinoin | Capsule, soft | 10 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| isotretinoin | Capsule, soft | 20 mg | Current | Limited Availability | Manufacturing | 29/01/2026 |
| lacosamide | Tablet, film coated | 100 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| temozolomide | Capsule, hard | 5 mg | Current | Limited Availability | Manufacturing | 29/01/2026 |
| lanreotide acetate | Injection, solution | 133.33 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| sodium nitroprusside | Injection, concentrated | 50 mg | Current | Unavailable | Commercial Changes / Commercial viability | 29/01/2026 |
| isotretinoin | Capsule, soft | 20 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| isotretinoin | Capsule, soft | 10 mg | Current | Unavailable | Manufacturing | 29/01/2026 |
| lidocaine hydrochloride | Injection, solution | 10 mg/mL | Anticipated | Available | Manufacturing | 29/01/2026 |
| nizatidine | Capsule, hard | 300 mg | Current | Limited Availability | Manufacturing | 29/01/2026 |
| chlorhexidine gluconate | Solution, irrigation | 30 mg | Current | Limited Availability | Manufacturing | 28/01/2026 |
| leflunomide | Tablet, film coated | 10 mg | Anticipated | Available | Manufacturing | 28/01/2026 |
| fluorouracil | Injection, solution | 5000 mg | Current | Unavailable | Unexpected increase in consumer demand | 28/01/2026 |
| pioglitazone hydrochloride | Tablet | 49.9 mg | Anticipated | Available | Manufacturing | 28/01/2026 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 28/01/2026 |
| rosuvastatin calcium | Tablet, film coated | 41.68 mg | Current | Unavailable | Manufacturing | 28/01/2026 |
| rosuvastatin calcium | Tablet, film coated | 10.42 mg | Current | Unavailable | Manufacturing | 28/01/2026 |
| rosuvastatin calcium | Tablet, film coated | 20.84 mg | Current | Unavailable | Unexpected increase in consumer demand | 28/01/2026 |
| pregabalin | Capsule, hard | 150 mg | Current | Limited Availability | Unexpected increase in consumer demand | 28/01/2026 |
| carbidopa monohydrate~entacapone~levodopa | Tablet, film coated | 27 mg~200 mg~100 mg | Resolved | Available | Unexpected increase in consumer demand | 28/01/2026 |
| ondansetron | Tablet, orally disintegrating | 4 mg | Current | Limited Availability | Manufacturing | 28/01/2026 |
| teriflunomide | Tablet, film coated | 14 mg | Current | Limited Availability | Manufacturing | 28/01/2026 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Manufacturing | 28/01/2026 |
| montelukast sodium | Tablet, film coated | 10.4 mg | Current | Limited Availability | Manufacturing | 28/01/2026 |
| finasteride | Tablet, film coated | 1 mg | Resolved | Available | Manufacturing | 28/01/2026 |
| lamotrigine | Tablet, chewable | 50 mg | Anticipated | Available | Manufacturing | 28/01/2026 |
| flecainide acetate | Tablet | 50 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 28/01/2026 |
| sodium chloride | Injection, solution | 90 mg | Resolved | Available | Manufacturing | 28/01/2026 |
| lidocaine hydrochloride monohydrate | Injection, solution | 10 mg/mL | Resolved | Available | Manufacturing | 28/01/2026 |
| levodopa~carbidopa monohydrate | Tablet, uncoated | 100 mg~26.9 mg | Current | Limited Availability | Manufacturing | 28/01/2026 |
| carbidopa monohydrate~entacapone~levodopa | Tablet, film coated | 27 mg~200 mg~100 mg | Resolved | Available | Manufacturing | 28/01/2026 |
| salbutamol sulfate | Inhalation, conventional | 6 mg | Current | Unavailable | Manufacturing | 27/01/2026 |
| salbutamol sulfate | Inhalation | 2.4 mg/mL | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 27/01/2026 |
| tranexamic acid | Tablet, film coated | 500 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 27/01/2026 |
| oxycodone hydrochloride | Tablet, uncoated | 5 mg | Anticipated | Available | Manufacturing | 27/01/2026 |
| mesalazine | Suppository, moulded | 1000 mg | Current | Limited Availability | Manufacturing | 27/01/2026 |
| tranexamic acid | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 27/01/2026 |
| trientine dihydrochloride | Capsule | 250 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 27/01/2026 |
| progesterone | Pessary | 400 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 27/01/2026 |
| olipudase alfa | Injection, powder for | 20 mg | Anticipated | Available | Manufacturing | 27/01/2026 |
| dantrolene sodium hemiheptahydrate | Capsule | 25 mg | Current | Unavailable | Manufacturing | 27/01/2026 |
| dantrolene sodium hemiheptahydrate | Capsule | 50 mg | Current | Unavailable | Manufacturing | 27/01/2026 |
| mefloquine hydrochloride | Tablet, uncoated | 274.09 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 27/01/2026 |
January 30, 2026
January 28, 2026
January 27, 2026
January 27, 2026
